Clinuvel Pharmaceuticals 's total assets for Q2 2026 were AU$269.70M, a decrease of -0.76% from the previous quarter. CLVLF total liabilities were AU$20.68M for the fiscal quarter, a -33.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.